RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Hamden, CT · New Haven, CT · +85 more sites
4 recruiting crohn's disease studies with a site in Hamden, CT.
Sponsor: Merck Sharp & Dohme LLC
Hamden, CT · New Haven, CT · +85 more sites
Sponsor: Janssen Research & Development, LLC
Hamden, CT · +38 more sites
Sponsor: Takeda
Hamden, CT · +40 more sites
Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd.
Hamden, CT · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.